Literature DB >> 594947

Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease.

R A Matthay, S K Zorn, M S Mitchell, R J Papac.   

Abstract

Two patients, aged 29 and 40, with nodular sclerosing Hodgkin's disease, in complete remission for four and six years respectively after intensive radiotherapy and combination chemotherapy, developed carcinoma of the lung in the previous radiation port. Although radiotherapy and chemotherapy can eradicate Hodgkin's disease involving the thorax, this treatment may be associated with the development of a secondary pulmonary malignancy, particularly in a previous radiation port, and several years may elapse before the new tumour becomes evident.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 594947      PMCID: PMC470803          DOI: 10.1136/thx.32.5.628

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Chemical immunosuppression and human cancer.

Authors:  I Penn
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

2.  Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.

Authors:  J C Arseneau; R W Sponzo; D L Levin; L E Schnipper; H Bonner; R C Young; G P Canellos; R E Johnson; V T DeVita
Journal:  N Engl J Med       Date:  1972-11-30       Impact factor: 91.245

3.  Experimental carcinogenesis. Bronchial intramural adenocarcinomas in rats from x-ray irradiation of the chest.

Authors:  P Gross; E A Pfitzer; J Watson; R T De Treville; M Kaschak; E B Tolker; M A Babyak
Journal:  Cancer       Date:  1969-05       Impact factor: 6.860

Review 4.  Immunosuppressive and cytotoxic chemotherapy: long-term complications.

Authors:  P S Schein; S H Winokur
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

Review 5.  Second malignant neoplasms associated with immunosuppressive medications.

Authors:  I Penn
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

6.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

  6 in total
  1 in total

1.  Lung cancer following therapy for Hodgkin's disease.

Authors:  L Oliphant; R G McFadden
Journal:  Can Med Assoc J       Date:  1985-03-01       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.